Skip to main navigation Skip to search Skip to main content

The use of botulinum toxin in Freys Syndrome.

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

Freys Syndrome, or gustatory sweating, occurs in over 50% of patients following superficial parotidectomy. In the vast majority of cases, these symptoms are not severe enough to require surgical treatment and can be effectively treated with topical anticholinergics and antihyperhydrotics. Patients with recalcitrant Freys Syndrome can be treated by a variety of surgical procedures. However, the potential risks and side effects of these surgical procedures often outweigh the benefits. Botulinum toxin A has recently emerged as a popular treatment option for a number of head and neck conditions. The anticholinergic effects of Botox make it particularly suitable for the treatment of Freys Syndrome. We report our experience.
Original languageEnglish (Ireland)
Number of pages2
JournalIr Med J
Volume99
Issue number5
Publication statusPublished - 1 May 2006

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Khoo SG, Keogh IJ, Timon C

Fingerprint

Dive into the research topics of 'The use of botulinum toxin in Freys Syndrome.'. Together they form a unique fingerprint.

Cite this